MAY 12, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Pyridostigmine Bromide (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for pyridostigmine bromide labeling change; regulatory action without clinical trial data or efficacy claims.
Reported
Approval date2026-05-12
Dose strength105 mg